Tag:
Omthera Pharmaceuticals
Latest Headlines
Latest Headlines
Omthera rounds up $34M in Series B, adds David Mott to board
With a Phase III study of its lead drug now under way, Omthera Pharmaceuticals is reporting that it has raised a hefty $33.9 million in its second round of venture cash. New Enterprise Associates
